Wordt geladen...
Medical Treatment of Benign Prostatic Hyperplasia
Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly impro...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MedReviews, LLC
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3151584/ https://ncbi.nlm.nih.gov/pubmed/21826125 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|